Literature DB >> 14725791

HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity.

Cornelia Bruder1, Magdalena Hagleitner, Gretchen Darlington, Iradj Mohsenipour, Reinhard Würzner, Isolde Höllmüller, Heribert Stoiber, Cornelia Lass-Flörl, Manfred P Dierich, Cornelia Speth.   

Abstract

Virus-induced complement expression and activation in the brain is hypothesized to contribute to the process of neurodegeneration in AIDS-associated neurological disorders. Previous experiments have shown that the human immunodeficiency virus (HIV) upregulates the low basal production of complement factor C3 in astrocytes and neurons. Since inhibition of complement synthesis and activation in the brain may represent a putative therapeutic goal to prevent virus-induced damage, we analysed the mechanism of the HIV-induced modulation of C3 expression. Detailed studies using different C3 promoter constructs revealed that HIV activates the synthesis of C3 by stimulation of the promoter. This HIV-induced promoter activation could be measured both in different astrocytic cell lines and in neurons. Deletion constructs of the C3 promoter defined the IL-6/IL-1beta responsive element within the promoter region as a central element for the responsiveness of the C3 promoter towards the influence of HIV. A binding site for the transcription factor C/EBPdelta was identified as important regulatory domain within the IL-6/IL-1beta responsive element, since a point mutation which eliminates the binding capacity of C/EBPdelta to this site also abolishes the induction by HIV-1. Similarly, the viral proteins Nef and gp41 which had also been shown to stimulate the synthesis of C3, exert their effect via the IL-6/IL-1beta responsive element with binding of the transcription factor C/EBPdelta representing the critical step. Our experiments clearly define the mechanism for the induction of complement factors in the HIV-infected brain and reveal a decisive role of the regulator protein C/EBPdelta for the HIV-induced increase in C3 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725791     DOI: 10.1016/j.molimm.2003.10.016

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics.

Authors:  Vivekananda Shetty; Pooja Jain; Zacharie Nickens; Gomathinayagam Sinnathamby; Anand Mehta; Ramila Philip
Journal:  OMICS       Date:  2011-10

2.  Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins.

Authors:  Ning Zhang; Quynh Ai Truong-Tran; Brian Tancowny; Kathleen E Harris; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

3.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

Authors:  Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

Review 4.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 5.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

6.  Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.

Authors:  Min Soon Cho; Rajesha Rupaimoole; Hyun-Jin Choi; Kyunghee Noh; Jichao Chen; Qianghua Hu; Anil K Sood; Vahid Afshar-Kharghan
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

7.  Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease.

Authors:  Paul B Larkin; Paul J Muchowski
Journal:  J Huntingtons Dis       Date:  2012

8.  Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis.

Authors:  Edward A Acheampong; Cassandra Roschel; Muhammad Mukhtar; Alagarsamy Srinivasan; Mohammad Rafi; Roger J Pomerantz; Zahida Parveen
Journal:  Virol J       Date:  2009-10-30       Impact factor: 4.099

9.  Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures.

Authors:  Sarah Jamali; Annick Salzmann; Nader Perroud; Magali Ponsole-Lenfant; Jennifer Cillario; Patrice Roll; Nathalie Roeckel-Trevisiol; Ariel Crespel; Jorg Balzar; Kurt Schlachter; Ursula Gruber-Sedlmayr; Ekaterina Pataraia; Christoph Baumgartner; Alexander Zimprich; Fritz Zimprich; Alain Malafosse; Pierre Szepetowski
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

10.  Regulation of complement component C3 in astrocytes by IL-1beta and morphine.

Authors:  Jeffrey Maranto; Jay Rappaport; Prasun K Datta
Journal:  J Neuroimmune Pharmacol       Date:  2007-11-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.